awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26785612-AB338FD2-C8BE-4101-9C56-E7021259C68C
Q26785612-AB338FD2-C8BE-4101-9C56-E7021259C68C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26785612-AB338FD2-C8BE-4101-9C56-E7021259C68C
Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer
P2860
Q26785612-AB338FD2-C8BE-4101-9C56-E7021259C68C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26785612-AB338FD2-C8BE-4101-9C56-E7021259C68C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0b05118a42724f3a8b0a8b5ee5436414a970fbb3
P2860
A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer.